After all the discussion about the results I figured I'd better read beyond the highlights section
" One particular example shows the limitations even for the use of biopsies to validate the 64Cu-SAR-bisPSMA PET findings, where the first biopsy of a lymph node had a negative histopathology result for PC, which turned out positive following the complete excision of the same lymph node (Figure 3, above)"
I found that rather tasty, 64Cu finding tumours that even biopsies miss
After all the discussion about the results I figured I'd better...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.07 |
Change
-0.020(0.39%) |
Mkt cap ! $1.580B | |||
| Open | High | Low | Value | Volume |
| $5.07 | $5.08 | $4.89 | $2.540M | 506.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4456 | $5.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.08 | 4500 | 2 |
View Market Depth
| Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |